Security key
810648105
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 26,737,974
- Total 13F value
- $134,225,727
- Share change
- -1,238,922
- Put/Call ratio
- 14%
- SEC-reported price per share
- $5.02
- Number of holders
- 76
- Value change
- -$7,908,753
- Number of buys
- 33
- Number of sells
- 43
- Shares outstanding
- 53,364,241
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
76
Top holders
10
SCPH full security history
Ownership snapshot
Full 13F holder table
scPharmaceuticals Inc. SEC filings
scPharmaceuticals Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
5AM Partners IV, LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
3/4/5
13F
Highest disclosed value: $34,858,241
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC has the largest disclosed position value at $34.86M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
5AM Partners IV, LLC
$17.48M
ORBIMED ADVISORS LLC
$34.86M
Rubric Capital Management LP
$21.94M
AIGH Capital Management LLC
$19.48M
BlackRock Finance, Inc.
$11.68M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 5AM Partners IV, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$17,475,704
2,734,852 shares
|
— | 06 Oct 2022 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$34,858,241
5,559,528 shares
|
— | 31 Dec 2023 |
| Rubric Capital Management LP |
13F
Company
|
—
denominator unverified
|
$21,945,000
3,500,000 shares
|
— | 31 Dec 2023 |
| AIGH Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$19,479,605
3,106,795 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$11,683,762
1,863,439 shares
|
— | 31 Dec 2023 |
| J. Goldman & Co LP |
13F
Company
|
—
denominator unverified
|
$8,806,886
1,404,607 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
76
Shares
26,737,974
Rows available
76
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
76
Q1 2024 holders
76
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|